Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Rationale and Design of the SOTA-P-CARDIA Trial (ATRU-V): Sotagliflozin in HFpEF Patients Without Diabetes

Title:	Rationale and Design of the SOTA-P-CARDIA Trial (ATRU-V): Sotagliflozin in HFpEF Patients Without Diabetes
Authors:	Pérez, Maeve Soto^{Aff1, Aff2, IDs10557023074696_cor1}; Rodríguez-Capitán, Jorge^{Aff1, Aff3, IDs10557023074696_cor2}; Requena-Ibáñez, Juan Antonio^{Aff1, Aff4}; Santos-Gallego, Carlos G.^{Aff1, Aff4}; Urooj Zafar, M.^{Aff1, Aff4}; Escolar, Ginés^{Aff1, Aff5}; Mancini, Donna^Aff4; Mitter, Sumeet^Aff4; Lam, David^Aff6; Contreras, Johanna P.^Aff4; Fergus, Icilma^Aff4; Atallah-Lajam, Farah^Aff4; Abascal, Vivian^Aff4; Lala, Anu^Aff4; Moreno, Pedro^Aff4; Moss, Noah^Aff4; Lerakis, Stamatios^Aff4; Sanz, Javier^Aff4; Fuster, Valentin^Aff4; Badimon, Juan José^{Aff1, Aff4, IDs10557023074696_cor3}
Source:	Cardiovascular Drugs and Therapy. 39(1):155-164
Database:	Springer Nature Journals